ResearcherKyoto UniversityActive in the last 2 years
Kei Yamane
Matched on ORCID iD 0000-0002-9543-0841; OpenAlex author ID A5006123220. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2023: 1 paper · 2024: none · 2025: 3 papers · 2026: 2 papers
Papers 6
- Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Retrospective S… Co-author DOI 10.1097/sla.0000000000007052↗
- Pancreatic Neuroendocrine Tumor with Acinar Pattern Mimicking Pancreatic Ductal Adenocarcinoma: A Case Report. First author DOI 10.70352/scrj.cr.26-0184↗
- Neoadjuvant chemoradiotherapy using moderately hypofractionated intensity-modulated radiotherapy for borderline resectable pancreatic cancer : Outcomes and pro… Co-author DOI 10.1007/s00066-025-02433-9↗
- Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatment benefits. Co-author DOI 10.1016/j.pan.2025.04.012↗
- Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery for Resectable Pancreatic Cancer: A Ret… Co-author DOI 10.1245/s10434-025-16956-z↗
- Preoperative Endoscopic Minor Papilla Sphincterotomy for Pancreas Divisum in a Patient with Pancreatic Cancer Who Underwent Laparoscopic Distal Pancreatectomy. Co-author DOI 10.1245/s10434-023-13975-6↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kazuyuki Nagai · 6 shared papers, 2023–2026 · strength 1.26
- Paper Pancreatic Neuroendocrine Tumor with Acinar Pattern Mimicking Pancreatic Ductal Adenocarcinoma: A Case Report. DOI 10.70352/scrj.cr.26-0184↗
- Paper Neoadjuvant chemoradiotherapy using moderately hypofractionated intensity-modulated radiotherapy for borderline resecta… DOI 10.1007/s00066-025-02433-9↗
- Paper Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinom… DOI 10.1097/sla.0000000000007052↗
- Etsuro Hatano · 6 shared papers, 2023–2026 · strength 1.26
- Paper Pancreatic Neuroendocrine Tumor with Acinar Pattern Mimicking Pancreatic Ductal Adenocarcinoma: A Case Report. DOI 10.70352/scrj.cr.26-0184↗
- Paper Neoadjuvant chemoradiotherapy using moderately hypofractionated intensity-modulated radiotherapy for borderline resecta… DOI 10.1007/s00066-025-02433-9↗
- Paper Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinom… DOI 10.1097/sla.0000000000007052↗
- Toshihiko Masui · 4 shared papers, 2023–2026 · strength 0.81
- Paper Neoadjuvant chemoradiotherapy using moderately hypofractionated intensity-modulated radiotherapy for borderline resecta… DOI 10.1007/s00066-025-02433-9↗
- Paper Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinom… DOI 10.1097/sla.0000000000007052↗
- Paper Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery… DOI 10.1245/s10434-025-16956-z↗
- Michio Yoshimura · 3 shared papers, 2025 · strength 0.62
- Paper Neoadjuvant chemoradiotherapy using moderately hypofractionated intensity-modulated radiotherapy for borderline resecta… DOI 10.1007/s00066-025-02433-9↗
- Paper Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatmen… DOI 10.1016/j.pan.2025.04.012↗
- Paper Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery… DOI 10.1245/s10434-025-16956-z↗
- Takahiro Iwai · 3 shared papers, 2025 · strength 0.62
- Paper Neoadjuvant chemoradiotherapy using moderately hypofractionated intensity-modulated radiotherapy for borderline resecta… DOI 10.1007/s00066-025-02433-9↗
- Paper Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatmen… DOI 10.1016/j.pan.2025.04.012↗
- Paper Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery… DOI 10.1245/s10434-025-16956-z↗
- Akihisa Fukuda · 3 shared papers, 2025 · strength 0.62
- Paper Neoadjuvant chemoradiotherapy using moderately hypofractionated intensity-modulated radiotherapy for borderline resecta… DOI 10.1007/s00066-025-02433-9↗
- Paper Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatmen… DOI 10.1016/j.pan.2025.04.012↗
- Paper Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery… DOI 10.1245/s10434-025-16956-z↗
- Asahi Sato · 2 shared papers, 2025–2026 · strength 0.41
- Paper Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinom… DOI 10.1097/sla.0000000000007052↗
- Paper Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatmen… DOI 10.1016/j.pan.2025.04.012↗
- Junichi Matsubara · 2 shared papers, 2025 · strength 0.41
- Paper Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatmen… DOI 10.1016/j.pan.2025.04.012↗
- Paper Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery… DOI 10.1245/s10434-025-16956-z↗
- Atsuko Kasajima · 1 shared paper, 2026 · strength 0.25
- Yasunori Shirakawa · 1 shared paper, 2026 · strength 0.25
- Shinya Okumura · 1 shared paper, 2026 · strength 0.25
- Günter Klöppel · 1 shared paper, 2026 · strength 0.25
- Ayaka Ogawa · 1 shared paper, 2025 · strength 0.21
- Ryo Ashida · 1 shared paper, 2025 · strength 0.21
- Masashi Kanai · 1 shared paper, 2025 · strength 0.21
- Takashi Mizowaki · 1 shared paper, 2025 · strength 0.21
- Shintaro Yagi · 1 shared paper, 2026 · strength 0.21
- Yuichiro Uchida · 1 shared paper, 2026 · strength 0.21
- Masato Narita · 1 shared paper, 2026 · strength 0.21
- Naoya Sasaki · 1 shared paper, 2026 · strength 0.21
- Yusuke Okamura · 1 shared paper, 2026 · strength 0.21
- Takashi Ito · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.